Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Ancila Desai
CFO & Company Secretary - MedAdvisor Solutions Ltd
Professional Bio
Ancila Desai
Chief Financial Officer & Company Secretary
MBA, CA, MBS, MAICD
Ancila joined MedAdvisor Solutions in October 2022 and serves as the Global CFO and Company Secretary.
Prior to this, Ancila held commercial leadership roles for over 20 years and brings diverse experience with a background in M&A, customer and supplier negotiations, and capital management. She has also worked across a variety of sectors, including FMCG, logistics, and biotechnology, working with ASX-listed companies such as Metcash Limited, IDT Australia Limited, Toll Holdings Limited, and US-based Hollister Inc. She was also the CFO/Company Secretary and acted as strategic counsel to the CEO at ASX-listed, IDT Australia (ASX: IDT), successfully steering the company back to profitability. Ancila also collaborated with the federal government’s COVID-19 task force to enable the manufacture of Australia’s first locally developed and manufactured mRNA COVID-19 vaccine candidate.
Ancila holds an Executive MBA from Melbourne Business School and a Masters in Business Systems from Monash University. She is a Chartered Accountant and is a current member of the Australian Institute of Company Directors.
Chief Financial Officer & Company Secretary
MBA, CA, MBS, MAICD
Ancila joined MedAdvisor Solutions in October 2022 and serves as the Global CFO and Company Secretary.
Prior to this, Ancila held commercial leadership roles for over 20 years and brings diverse experience with a background in M&A, customer and supplier negotiations, and capital management. She has also worked across a variety of sectors, including FMCG, logistics, and biotechnology, working with ASX-listed companies such as Metcash Limited, IDT Australia Limited, Toll Holdings Limited, and US-based Hollister Inc. She was also the CFO/Company Secretary and acted as strategic counsel to the CEO at ASX-listed, IDT Australia (ASX: IDT), successfully steering the company back to profitability. Ancila also collaborated with the federal government’s COVID-19 task force to enable the manufacture of Australia’s first locally developed and manufactured mRNA COVID-19 vaccine candidate.
Ancila holds an Executive MBA from Melbourne Business School and a Masters in Business Systems from Monash University. She is a Chartered Accountant and is a current member of the Australian Institute of Company Directors.